Oskar Foundation Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial
2000
NCT00894816
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

ferrous sulfate (1 trial)

Drugs in Phase 3 Trials (1)

lactobacillus casei (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 4)

Birth Weight (Phase 4)

Child Behavior Disorders (Phase 4)

Dental Caries (Phase 3)

Eczema (Phase 3)

Hypersensitivity (Phase 3)

Mental Disorders (Phase 4)

Neurobehavioral Manifestations (Phase 4)

Obesity (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2